XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.3

Accounts Payable and Accrued Expenses

9 Months Ended

Sep. 30, 2024

Accounts Payable and Accrued Expenses

Accounts Payable and Accrued Expenses

4. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses is comprised of the following as of September 30, 2024 and December 31, 2023:

​

​	​	​	​	​	​	​
​		September 30, 2024			December 31, 20231
Accrued research and development costs	​	$	8,760	​	$	6,091
Accrued 2023 Lilly License costs	​	​	5,000	​	​	10,000
Accounts payable	​		1,014	​	​	2,749
Accrued bonus	​		1,361	​	​	1,201
Accrued professional fees	​	​	948	​	​	150
Accrued withholding taxes payable	​	​	584	​	​	—
Other accrued expenses	​	​	577	​	​	111
Total accounts payable and accrued expenses	​	$	18,244	​	$	20,302

(1) Comparative figures have been reclassified to conform with current period presentation.

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483384/720-30-45-1

+ Details

Name:	us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration